(Q38076496)

28 August 2017

0 references

1 reference

title

Cardiovascular aspects of psoriasis: an updated review. (English)

1 reference

28 August 2017

5

Piotr Paluszkiewicz

1 reference

28 August 2017

4

Jacek C Szepietowski

1 reference

28 August 2017

2

Joanna Bartosińska

1 reference

28 August 2017

3

Grazyna Chodorowska

1 reference

28 August 2017

Aldona Pietrzak

1

0 references

author name string

Robert A Schwartz

series ordinal

6

1 reference

28 August 2017

publication date

1 February 2013

1 reference

International Journal of Dermatology

28 August 2017

published in

1 reference

28 August 2017

volume

52

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

153-162

1 reference

More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Heart disease in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis and occlusive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis: an opportunity to identify cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis patients show signs of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Pathogenic Mechanisms Shared between Psoriasis and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis and metabolic disease: epidemiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

C-reactive protein and alpha2-macroglobulin plasma activity in medium-severe and severe psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Homocysteine, vitamin B12 and folic acid levels in psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

AJC editor's consensus: psoriasis and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Disease concomitance in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Serum leptin levels, skin leptin and leptin receptor expression in psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Guidelines to evaluate human observational studies for quantitative risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis and cardiovascular risk: strength in numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis and cardiovascular risk: strength in numbers, part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis: a possible risk factor for development of coronary artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Myocardial perfusion is preserved in patients with psoriasis without clinically evident cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Subclinical atherosclerosis in patients with chronic psoriasis: a potential association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Chronic plaque psoriasis is associated with increased arterial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Cardiovascular reactivity to experimental stress in psoriasis: a controlled investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis-induced postoperative cardiac failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis and dilated cardiomyopathy: coincidence or associated diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Attributable risk estimate of severe psoriasis on major cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4632.2012.05584.X

10.1111/J.1365-4632.2012.05584.X

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference